Similarly, another study demonstrated that CA9 overexpression, observed in approximately 61.8% (63/102) of HCC tumor samples, not only reflects a hypoxic and highly malignant tumor phenotype but also functions as a powerful, independent biomarker for unfavorable postoperative outcomes, including shortened survival and higher recurrence rates (46). This evidence concerns the gene CA9 and hepatocellular carcinoma.